Equities

Axonics Inc

Axonics Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)68.97
  • Today's Change0.07 / 0.10%
  • Shares traded743.97k
  • 1 Year change+25.67%
  • Beta0.5581
Data delayed at least 15 minutes, as of Mar 28 2024 20:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Axonics, Inc. is a medical technology company, which develops and commercializes products to treat adults with bladder and bowel dysfunction. The Company has designed and developed both rechargeable (R20) and recharge-free (F15) implantable sacral neuromodulation (SNM) systems, which deliver mild electrical pulses to the targeted sacral nerve in order to restore normal communication to and from the brain to reduce the symptoms of overactive bladder (OAB), urinary retention (UR) and fecal incontinence (FI). The recharge-free implantable neurostimulator (INS) is approximately 10cc in volume, utilizes constant current stimulation, an easy-to-use, intuitive recharge-free patient remote control and other related accessories. It engineered its recharge-free sacral neuromodulation (SNM) system to deliver constant-current stimulation. Its SNM system includes an easy-to-use wireless patient remote control that does not require recharging or replacement batteries.

  • Revenue in USD (TTM)366.38m
  • Net income in USD-6.09m
  • Incorporated2012
  • Employees797.00
  • Location
    Axonics Inc26 Technology DriveIRVINE 92618United StatesUSA
  • Phone+1 (949) 396-6322
  • Fax+1 (949) 396-6321
  • Websitehttps://www.axonics.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
TransMedics Group Inc241.62m-25.03m2.42bn584.00--17.61--10.01-0.7685-0.76857.434.200.49152.705.30413,738.00-5.09-16.08-5.53-17.9563.7765.37-10.36-40.478.49--0.7868--158.5379.3630.92--225.12--
Conmed Corp1.24bn64.46m2.46bn4.00k39.232.9518.081.982.042.0439.6727.120.54151.755.74311,185.802.800.89723.231.0254.3354.955.181.650.95693.030.5386139.1619.067.68179.9910.042.890.00
Patterson Companies, Inc.6.57bn193.86m2.48bn7.60k13.632.568.850.37722.032.0368.8610.782.235.6114.48864,047.906.580.370211.300.565521.3021.052.950.18110.724312.080.4462846.10-0.42983.442.1410.798.220.00
Procept Biorobotics Corp136.19m-105.90m2.52bn626.00--8.94--18.49-2.24-2.242.885.530.38151.914.28217,557.50-29.66---33.47--52.17---77.75--6.77--0.1546--81.55---21.51------
ICU Medical Inc2.26bn-29.66m2.59bn14.00k--1.2212.941.15-1.23-1.2393.5587.960.50802.1611.79161,366.10-0.66691.46-0.74911.6532.7534.11-1.312.231.060.64840.43450.00-0.915410.0460.08---1.45--
Premier Inc1.32bn167.33m2.65bn2.80k15.851.119.012.011.391.3910.9719.950.35714.573.06470,033.204.4210.395.6713.0067.1362.0412.3722.601.32516.340.243119.11-6.762.44-34.17-15.30-2.29--
Helen of Troy Limited2.00bn162.04m2.74bn1.90k17.041.7313.001.376.766.7683.2766.810.65792.254.131,051,199.005.338.626.4610.8245.9543.168.109.720.97554.820.3168---6.786.98-35.97-0.48866.65--
Inari Medical Inc493.63m-1.64m2.78bn1.30k--5.96529.305.63-0.0318-0.03188.608.050.83781.577.67379,716.90-0.2777-0.5941-0.3129-0.669688.0389.06-0.3314-0.62952.52--0.00--28.73135.4094.41--52.46--
LivaNova PLC1.15bn17.55m3.02bn2.90k173.602.3644.482.620.32220.322221.3223.700.48832.765.79397,774.100.7472-6.010.8627-7.4266.8666.991.53-13.562.511.100.3147--12.890.8278120.34---1.64--
Enovis Corp1.71bn-54.37m3.41bn6.55k--0.997420.892.00-0.9987-0.611731.3362.610.38881.596.11260,640.80-1.23-0.3569-1.37-0.4158.2148.19-3.15-1.061.161.020.1199--9.22-4.89-40.29--11.91--
Axonics Inc366.38m-6.09m3.52bn797.00--5.49551.719.60-0.1285-0.12857.4312.560.53131.357.18459,697.60-0.8828-12.67-0.9601-13.7674.9470.04-1.66-29.688.98--0.00--33.86249.0689.80--23.65--
Envista Holdings Corp2.57bn-100.20m3.67bn12.80k--0.8785103.611.43-0.6022-0.602214.6524.340.38913.996.41200,507.80-1.521.94-1.792.3456.5257.65-3.905.291.905.120.26610.00-0.1012-2.04-142.10---4.22--
Integer Holdings Corp1.60bn90.65m3.90bn10.50k43.492.5620.572.442.682.6847.3045.580.55665.255.15152,064.103.163.283.433.5326.3026.945.686.401.713.540.38980.0016.035.6238.719.3321.71--
Lantheus Holdings Inc1.30bn326.66m4.27bn834.0013.415.2311.033.294.644.6418.5911.910.87239.465.211,554,471.0021.986.6925.757.7363.7153.9025.209.025.451,235.430.40810.0038.6530.441,063.8651.8135.48--
Haemonetics Corporation1.27bn126.57m4.33bn3.03k34.544.5919.703.412.472.4724.8018.570.62292.116.47418,649.006.214.747.055.8953.4849.779.977.411.7625.450.480.0017.675.27166.059.488.06--
Merit Medical Systems Inc1.26bn94.41m4.39bn6.95k46.823.6523.803.491.621.6221.5520.780.63042.367.34180,916.004.732.455.302.7746.4444.507.513.913.959.890.40640.009.247.3326.7015.86-11.16--
Data as of Mar 28 2024. Currency figures normalised to Axonics Inc's reporting currency: US Dollar USD

Institutional shareholders

48.08%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Dec 20235.12m10.08%
Fidelity Management & Research Co. LLCas of 31 Dec 20234.05m7.97%
BlackRock Fund Advisorsas of 31 Dec 20233.67m7.24%
Champlain Investment Partners LLCas of 31 Dec 20231.92m3.78%
Bellevue Asset Management AGas of 31 Dec 20231.83m3.61%
BAMCO, Inc.as of 31 Dec 20231.80m3.54%
Invesco Advisers, Inc.as of 31 Dec 20231.80m3.54%
AXA Investment Managers UK Ltd.as of 31 Dec 20231.56m3.08%
FIAM LLCas of 31 Dec 20231.36m2.69%
Loomis, Sayles & Co. LPas of 31 Dec 20231.30m2.56%
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.